Immunological aspects of cancer chemotherapy

Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome

Galon, J., Costes, A., Sanchez-Cabo, F., Kirilovsky, A., Mlecnik, B., Lagorce-Pagès, C., Tosolini, M., Camus, M., Berger, A., Wind, P., et al. (2006) · Science · doi:10.1126/science.1129139 · Cited by 6,516

Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009

Kroemer, G., Galluzzi, L., Vandenabeele, P., Abrams, J., Alnemri, E. S., Baehrecke, E. H., Blagosklonny, M. V., El-Deiry, W. S., Golstein, P., Green, D. R., et al. (2009) · Cell Death & Differentiation · doi:10.1038/cdd.2008.150 · Cited by 3,399

Calreticulin exposure dictates the immunogenicity of cancer cell death

Obeid, M., Tesniere, A., Ghiringhelli, F., Fimia, G. M., Apetoh, L., Perfettini, J.-L., Castedo, M., Mignot, G., Panaretakis, T., Casares, N., et al. (2007) · Nature Medicine · doi:10.1038/nm1523 · Cited by 3,216

Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

Apetoh, L., Ghiringhelli, F., Tesniere, A., Obeid, M., Ortiz, C., Criollo, A., Mignot, G., Maiuri, M. C., Ullrich, E., Saulnier, P., et al. (2007) · Nature Medicine · doi:10.1038/nm1622 · Cited by 3,056 · cited 1×

IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity

Shankaran, V., Ikeda, H., Bruce, A. T., White, J. M., Swanson, P. E., Old, L. J., & Schreiber, R. D. (2001) · Nature · doi:10.1038/35074122 · Cited by 2,896

Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes

Dudley, M. E., Wunderlich, J. R., Robbins, P. F., Yang, J. C., Hwu, P., Schwartzentruber, D. J., Topalian, S. L., Sherry, R., Restifo, N. P., Hubicki, A. M., et al. (2002) · Science · doi:10.1126/science.1076514 · Cited by 2,823

Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas

Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., & Lowe, S. W. (2007) · Nature · doi:10.1038/nature05529 · Cited by 2,473

A cytokine-mediated link between innate immunity, inflammation, and cancer

Lin, W.-W., & Karin, M. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31537 · Cited by 1,940

Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy

Reits, E. A., Hodge, J. W., Herberts, C. A., Groothuis, T. A., Chakraborty, M., K.Wansley, E., Camphausen, K., Luiten, R. M., de Ru, A. H., Neijssen, J., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052494 · Cited by 1,737

Adoptive Cell Transfer Therapy Following Non-Myeloablative but Lymphodepleting Chemotherapy for the Treatment of Patients With Refractory Metastatic Melanoma

Dudley, M. E., Wunderlich, J. R., Yang, J. C., Sherry, R. M., Topalian, S. L., Restifo, N. P., Royal, R. E., Kammula, U. S., White, D. E., Mavroukakis, S. A., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.00.240 · Cited by 1,625

Differential Influence of Anticancer Treatments and Angiogenesis on the Seric Titer of Autoantibody Used as Tumor and Metastasis Biomarker

Defresne, F., Bouzin, C., Guilbaud, C., Dieu, M., Delaive, E., Michiels, C., Raes, M. J., & Féron, O. (2010) · Neoplasia · doi:10.1593/neo.10238 · Cited by 19

Immune-based therapeutics for pediatric cancer

Capitini, C. M., Mackall, C. L., & Wayne, A. S. (2009) · Expert Opinion on Biological Therapy · doi:10.1517/14712590903431022 · Cited by 19

Can Antitumor Immunity Help to Explain “Oncogene Addiction”?

Restifo, N. P. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.11.002 · Cited by 19

Adoptive immunotherapy of metastatic breast cancer: present and future

Stefanovic, S., Schütz, F., Sohn, C., Beckhove, P., & Domschke, C. (2013) · Cancer and Metastasis Reviews · doi:10.1007/s10555-013-9452-6 · Cited by 19

Nanoparticles: A Promising Modality in the Treatment of Sarcomas

Susa, M., Milane, L. S., Amiji, M. M., Hornicek, F. J., & Duan, Z. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0173-z · Cited by 19

Induction of apoptosis through ER stress and TP53 in MCF-7 cells by the nanoparticle [Gd@C82(OH)22]n: A systems biology study

Wang, L., Meng, J., Cao, W., Li, Q., Qiu, Y., Sun, B., & Li, L. M. (2014) · Methods · doi:10.1016/j.ymeth.2014.01.007 · Cited by 18

Current and future immunotherapeutic approaches in Hodgkin lymphoma

Bröckelmann, P. J., Borchmann, P., & Engert, A. (2016) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2016.1185789 · Cited by 19

Cancer Immunotherapy Getting Brainy: Visualizing the Distinctive CNS Metastatic Niche to Illuminate Therapeutic Resistance

Owyong, M., Hosseini-Nassab, N., Efe, G., Honkala, A. T., van den Bijgaart, R. J. E., Plaks, V., & Smith, B. R. (2017) · Drug Resistance Updates · doi:10.1016/j.drup.2017.10.001 · Cited by 19

A robust approach to sample size calculation in cancer immunotherapy trials with delayed treatment effect

Ye, T., & Yu, M.-G. (2018) · Biometrics · doi:10.1111/biom.12916 · Cited by 20

Development and validation of nomograms integrating immune‐related genomic signatures with clinicopathologic features to improve prognosis and predictive value of triple‐negative breast cancer: A gene expression‐based retrospective study

Wang, K., Li, H., Xiong, Y., Shi, Y., Li, Z., Li, J., Zhang, X., & Li, H. (2019) · Cancer Medicine · doi:10.1002/cam4.1880 · Cited by 19

Immunosuppressive Signaling Pathways as Targeted Cancer Therapies

Damane, B. P., Hull, R., Bida, M., Durandt, C., Mulaudzi, T. V., Chatziioannou, A. A., & Dlamini, Z. (2022) · Biomedicines · doi:10.3390/biomedicines10030682 · Cited by 20

High Infiltration of CD68+/CD163− Macrophages Is an Adverse Prognostic Factor after Neoadjuvant Chemotherapy in Esophageal and Gastric Adenocarcinoma

Svensson, M. C., Svensson, M., Nodin, B., Borg, D., Hedner, C., Hjalmarsson, C., Leandersson, K., & Jirström, K. (2022) · Journal of Innate Immunity · doi:10.1159/000524434 · Cited by 19

Nanocarrier-based immunotherapy in cancer management and research

Bhaskar, S., & Singh, M. S. (2014) · ImmunoTargets and Therapy · doi:10.2147/itt.s62471 · Cited by 19

Erratum to “Unexpected High Response Rate to Traditional Therapy after Dendritic Cell-Based Vaccine in Advanced Melanoma: Update of Clinical Outcome and Subgroup Analysis”

Ridolfi, L., Petrini, M., Fiammenghi, L., Granato, A. M., Ancarani, V., Pancisi, E., Scarpi, E., Guidoboni, M., Migliori, G., Sanna, S., et al. (2011) · Clinical and Developmental Immunology · doi:10.1155/2011/283896 · Cited by 19

Chemotherapeutic agents induce mitochondrial superoxide production and toxicity but do not alter respiration in skeletal muscle in vitro

Rybalka, E., Timpani, C. A., Cheregi, B. D., Sorensen, J. C., Nurgali, K., & Hayes, A. (2017) · Mitochondrion · doi:10.1016/j.mito.2017.10.010 · Cited by 18

Expression patterns and prognostic implications of tumor-infiltrating lymphocytes dynamics in early breast cancer patients receiving neoadjuvant therapy: A systematic review and meta-analysis

Zhu, Y., Tzoras, E., Matikas, A., Bergh, J. C. S., Valachis, A., Zerdes, I., & Foukakis, T. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.999843 · Cited by 18

Immunogenic chemotherapy: great potential for improving response rates

Huang, X., Ren, Q., Yang, L., Cui, D., Ma, C., Zheng, Y., & Wu, J. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1308681 · Cited by 21

Carbon dot-modified controllable drug delivery system for sonodynamic/chemotherapy of tumors

Meng, Q., Wang, Q., Zhang, Q., Wang, J., Li, Y., Zhu, S., Liu, R., & Zhu, H. (2024) · Materials Chemistry Frontiers · doi:10.1039/d3qm01135f · Cited by 18

Prediction of Response to Neoadjuvant Chemotherapy: New Biomarker Approaches and Concepts

Denkert, C., Sinn, B. V., Issa, Y., Müller, B. M., Maisch, A., Untch, M., von Minckwitz, G., & Loibl, S. (2011) · Breast Care · doi:10.1159/000331696 · Cited by 18

Dacarbazine mediates antimelanoma effects via NK cells

Hervieu, A., Mignot, G., & Ghiringhelli, F. (2013) · OncoImmunology · doi:10.4161/onci.23714 · Cited by 18

From clinical trials to clinical practice: therapeutic cancer vaccines for the treatment of prostate cancer

Madan, R. A., Aragon‐Ching, J. B., Gulley, J. L., & Dahut, W. L. (2011) · Expert Review of Vaccines · doi:10.1586/erv.11.70 · Cited by 18

Systematic Review and Cumulative Analysis of the Combination of Mitomycin C plus Bacillus Calmette-Guérin (BCG) for Non–Muscle-Invasive Bladder Cancer

Deng, T., Liu, B., Duan, X., Zhang, T., Cai, C., & Zeng, G. (2017) · Scientific Reports · doi:10.1038/s41598-017-03421-5 · Cited by 18

Luciferase-assisted detection of extracellular ATP and ATP metabolites during immunogenic death of cancer cells

Dubyak, G. (2019) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2019.10.006 · Cited by 19

Neglected, Drug-Induced Platinum Accumulation Causes Immune Toxicity

Zhang, Y., Zheng, J., Jiang, Y., Huang, X., & Fang, L. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01166 · Cited by 18

Emergence of novel targeting systems and conventional therapies for effective cancer treatment

Gautam, L., Jain, A., Shrivastava, P., Vyas, S., & Vyas, S. P. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819793-6.00002-3 · Cited by 18

Chemoimmunotherapy for the treatment of prostate cancer: Insights from mathematical modelling

Valle, P. A., Coria, L. N., & Carballo, K. D. (2020) · Applied Mathematical Modelling · doi:10.1016/j.apm.2020.09.021 · Cited by 18

Implementing biological markers as a tool to guide clinical care of patients with pancreatic cancer

Iovanna, J. (2021) · Translational Oncology · doi:10.1016/j.tranon.2020.100965 · Cited by 18

α-Tocopheryloxyacetic acid: a novel chemotherapeutic that stimulates the antitumor immune response

Hahn, T., Jagadish, B., Mash, E. A., Garrison, K., & Akporiaye, E. T. (2011) · Breast Cancer Research · doi:10.1186/bcr2808 · Cited by 18

A trial of autologous ex vivo-expanded NK cell-enriched lymphocytes with docetaxel in patients with advanced non-small cell lung cancer as second- or third-line treatment: phase IIa study.

Yang, Y. J., Park, J. C., Kim, H. K., Kang, J. H., & Park, S. Y. (2013) · PubMed · Cited by 18

Discovery of a Chimeric Polyketide Family as Cancer Immunogenic Chemotherapeutic Leads

Xue, D., Xu, M., Madden, M. D., Lian, X., Older, E. A., Pulliam, C., Hui, Y. Y., Shang, Z., Gupta, G., Raja, M. R. K., et al. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.4c09582 · Cited by 18

A Review on ZnO-based Targeted Drug Delivery System

Chawla, U., Dahiya, D., Kumar, Y., Bala, A., Genwa, M., Agasti, N., Tandon, S., Singh, S. P., & Meena, P. L. (2023) · Letters in Drug Design & Discovery · doi:10.2174/1570180820666230222092950 · Cited by 17

Exosomes as a drug delivery tool for cancer therapy: a new era for existing drugs and oncolytic viruses

Kakiuchi, Y., Kuroda, S., Kanaya, N., Kagawa, S., Tazawa, H., & Fujiwara, T. (2023) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2023.2259102 · Cited by 16

SOCS1 expression in cancer cells: potential roles in promoting antitumor immunity

Ilangumaran, S., Gui, Y., Shukla, A., & Ramanathan, S. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1362224 · Cited by 18

Herbal based nanoparticles as a possible and potential treatment of cancer: a review

Yadav, R., Chawra, H. S., Dubey, G., Alam, M. S., Kumar, V., Sharma, P., Upadhyay, N. K., & Yadav, T. (2025) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2025.1002285 · Cited by 20

Exploiting Synergy: Immune-Based Combinations in the Treatment of Prostate Cancer

Burotto, M., Singh, N. K., Heery, C. R., Gulley, J. L., & Madan, R. A. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00351 · Cited by 17

Pathogenic, immunologic, and clinical aspects of sepsis – update 2016

Uhle, F., Chousterman, B. G., Grützmann, R., Brenner, T., & Weber, G. F. (2016) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2016.1224971 · Cited by 17

Prognostic implication of HSPA (HSP70) in breast cancer patients treated with neoadjuvant anthracycline-based chemotherapy

Nadin, S. B., Sottile, M. L., Guevara, M. M. M., Gauna, G. V., Daguerre, P., Leuzzi, M., Gago, F. E., Ibarra, J., Cuello-Carrión, F. D., Ciocca, D. R., et al. (2013) · Cell Stress and Chaperones · doi:10.1007/s12192-013-0475-2 · Cited by 17

Knockdown of RAP2A gene expression suppresses cisplatin resistance in gastric cancer cells

Zhang, J., Wei, Y., Min, J., Wang, Y., Yin, L., Cao, G., & Shen, H. (2019) · Oncology Letters · doi:10.3892/ol.2019.11086 · Cited by 17

The paradox of cancer cell apoptosis

Bruce, C. B. (2010) · Frontiers in bioscience · doi:10.2741/3819 · Cited by 17

Exploring the Multifunctional Role of Alpha-Fetoprotein in Cancer Progression: Implications for Targeted Therapy in Hepatocellular Carcinoma and Beyond

Kim, H. J., Jang, M., & Kim, E. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26104863 · Cited by 16

Novel Opportunities to Use Radiation Therapy with Immune Checkpoint Inhibitors for Melanoma Management

Ahmed, K. A., Kim, S., & Harrison, L. B. (2017) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2017.01.007 · Cited by 16

DPPG2-based thermosensitive liposomes as drug delivery system for effective muscle-invasive bladder cancer treatment in vivo

Brummelhuis, I. S. G., Simons, M., Lindner, L. H., Kort, S., de Jong, S., Hossann, M., Witjes, J. A., & Oosterwijk, E. (2021) · International Journal of Hyperthermia · doi:10.1080/02656736.2021.1983038 · Cited by 16

Evolution and Targeting of Myeloid Suppressor Cells in Cancer: A Translational Perspective

Bleve, A., Consonni, F. M., Porta, C., Garlatti, V., & Sica, A. (2022) · Cancers · doi:10.3390/cancers14030510 · Cited by 17

Role of CD47-SIRPα Checkpoint in Nanomedicine-Based Anti-Cancer Treatment

Liao, H., & Niu, C. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.887463 · Cited by 16

Improvement of TNBC immune checkpoint blockade with a microwave-controlled ozone release nanosystem.

Song, L., Zheng, D., Xu, J.-S., Xu, T., Liu, Z., Zhang, H., Li, Y., Peng, Y., & Shi, H.-B. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.09.053 · Cited by 15

A modulatory effect of L-arginine supplementation on anticancer effects of chemoimmunotherapy in colon cancer-bearing aged mice

Ishitobi, K., Kotani, H., Iida, Y., Taniura, T., Notsu, Y., Tajima, Y., & Harada, M. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109423 · Cited by 15

Chemotherapeutics Used for High-Risk Neuroblastoma Therapy Improve the Efficacy of Anti-GD2 Antibody Dinutuximab Beta in Preclinical Spheroid Models

Troschke‐Meurer, S., Zumpe, M., Meißner, L., Siebert, N., Grabarczyk, P., Forkel, H., Maletzki, C., Bekeschus, S., & Lode, H. N. (2023) · Cancers · doi:10.3390/cancers15030904 · Cited by 16

Carbon nanoparticles-Fe(II) complex for efficient theranostics of xenografted colonic tumor

Xie, P., Huang, Y., Tang, K., Wu, X., Zeng, C. C., Yang, S., & Tang, X. (2023) · Cancer Nanotechnology · doi:10.1186/s12645-023-00196-5 · Cited by 16

Intrinsic suppression of type I interferon production underlies the therapeutic efficacy of IL-15-producing natural killer cells in B-cell acute lymphoblastic leukemia

Kumar, A., Khani, A. T., Duault, C., Aramburo, S., Ortiz, A. S., Lee, S. J., Chan, A., McDonald, T., Huang, M., Lacayo, N. J., et al. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-006649 · Cited by 16

Low-dose metronomic chemotherapy triggers oxidized mtDNA sensing inside tumor cells to potentiate CD8+T anti-tumor immunity

Qiao, W., Hu, C., Ma, J., Dong, X., Dalangood, S., Li, H., Yuan, C., Lu, B., Gao, W., Wen, Z., et al. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216370 · Cited by 17

Choline Carboxylic Acid Ionic Liquid-Stabilized Anisotropic Gold Nanoparticles for Photothermal Therapy

Vashisth, P., Smith, C. L., Amarasekara, D. L. Y., Dasanyake, G. S., Singh, G., Chism, C. M., Hamadani, C. M., Shaikh, T., Grovich, N., Gamboa, B. G., et al. (2024) · ACS Applied Nano Materials · doi:10.1021/acsanm.3c04645 · Cited by 16

Anti-survivin antibody responses in lung cancer

Karanikas, V., Khalil, S. A., Kerenidi, T., Gourgoulianis, K. I., & Germenis, A. E. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.03.015 · Cited by 16

1-Palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol (PLAG) attenuates gemcitabine-induced neutrophil extravasation

Jeong, J., Kim, Y., Lee, D. Y., Moon, B.-G., Sohn, K., Yoon, S. Y., & Kim, J. W. (2019) · Cell & Bioscience · doi:10.1186/s13578-018-0266-7 · Cited by 16

Combination Strategies of Checkpoint Immunotherapy in Metastatic Breast Cancer

Liu, Z. B., Zhang, L., Bian, J., & Jian, J. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s240655 · Cited by 17

Serum and Glucocorticoid-Inducible Kinase 1 (SGK1) in NSCLC Therapy

Guerriero, I., Monaco, G., Coppola, V., & Orlacchio, A. (2020) · Pharmaceuticals · doi:10.3390/ph13110413 · Cited by 17

Multi-Omics Profiling of the Tumor Microenvironment

Oekelen, O. V., & Laganà, A. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-91836-1_16 · Cited by 13

Past, Present and Future Strategies of Immunotherapy in Gynecological Malignancies

Bellati, F., Napoletano, C., Ruscito, I., Visconti, V. V., Antonilli, M., Gasparri, M. L., Zizzari, I. G., Rahimi, H., Palaia, I., Rughetti, A., et al. (2013) · Current Molecular Medicine · doi:10.2174/1566524011313040014 · Cited by 16

Expression of CCL21 in Ewing sarcoma shows an inverse correlation with metastases and is a candidate target for immunotherapy

Sand, L. G. L., Berghuis, D., Szuhai, K., & Hogendoorn, P. C. W. (2016) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-016-1862-1 · Cited by 16

Immunostimulatory Effect of Zanthoxylum schinifolium‐Based Complex Oil Prepared by Supercritical Fluid Extraction in Splenocytes and Cyclophosphamide‐Induced Immunosuppressed Rats

Lee, H. Y., Park, Y. M., Lee, Y. H., Kang, Y. G., Lee, H. M., Park, D. S., Yang, H. J., Kim, M. J., & Lee, Y. (2018) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2018/8107326 · Cited by 16

Cytotoxic effects of ex vivo-expanded natural killer cell-enriched lymphocytes (MYJ1633) against liver cancer

Choi, J., Lee, E. S., Kim, S. Y., Park, S. I., Oh, S., Kang, J. H., Ryu, H. A., & Lee, S. (2019) · BMC Cancer · doi:10.1186/s12885-019-6034-1 · Cited by 16

Interleukin-21 restrains tumor growth and induces a substantial increase in the number of circulating tumor-specific T cells in a murine model of malignant melanoma

Petersen, C. C., Diernæs, J. E. F., Skovbo, A., Hvid, M., Deleuran, B. W., & Hokland, M. (2009) · Cytokine · doi:10.1016/j.cyto.2009.11.001 · Cited by 16

Dual Src Kinase/Pretubulin Inhibitor KX-01, Sensitizes ERα-negative Breast Cancers to Tamoxifen through ERα Reexpression

Anbalagan, M., Sheng, M., Fleischer, B. P., Zhang, Y., Gao, Y., Hoang, V., Matossian, M. D., Burks, H. E., Burow, M. E., Collins‐Burow, B. M., et al. (2017) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0297-t · Cited by 16

Diagnostic and Therapeutic Implications of Tumor-Infiltrating Lymphocytes in Breast Cancer

Denkert, C. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.47.1698 · Cited by 17

Application of a Novel Metallomics Tool to Probe the Fate of Metal-Based Anticancer Drugs in Blood Plasma: Potential, Challenges and Prospects

Sarpong‐Kumankomah, S., & Gailer, J. (2020) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026620666200628023540 · Cited by 15

Composite Hydrogels with Included Solid-State Nanoparticles Bearing Anticancer Chemotherapeutics

Zhivkov, A. M., Popov, T. T., & Hristova, S. H. (2023) · Gels · doi:10.3390/gels9050421 · Cited by 16

Antimicrobial activity of biosynthesized Cuo/Se nanocomposite against Helicobacter pylori

Baker, D. H. A., & Abbas, H. S. (2023) · Arabian Journal of Chemistry · doi:10.1016/j.arabjc.2023.105095 · Cited by 16

PUMA/RIP3 Mediates Chemotherapy Response via Necroptosis and Local Immune Activation in Colorectal Cancer

Chen, D., Ermine, K., Wang, Y.-J., Chen, X., Lu, X., Wang, P., Stolz, D. B., Yu, J., & Zhang, L. (2023) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-23-0162 · Cited by 15

A CTL‐Inspired Killing System Using Ultralow‐Dose Chemical‐Drugs to Induce a Pyroptosis‐Mediated Antitumor Immune Function

Hao, Y., Xie, C., Zuo, Z., Xie, D., & Wang, Q. (2023) · Advanced Materials · doi:10.1002/adma.202309839 · Cited by 15

Chitosan/dextran-based organohydrogel delivers EZH2 inhibitor to epigenetically reprogram chemo/immuno-resistance in unresectable metastatic melanoma

Tang, Q., Leng, S., Tan, Y., Cheng, H., Liu, Q., Wang, Z., Xu, Y., Zhu, L., & Wang, C. (2024) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2024.122645 · Cited by 15

Endoplasmic Reticulum Stress Nano‐Orchestrators for Precisely Regulated Immunogenic Cell Death as Potent Cancer Vaccines

Teng, Y., Yang, Z., Peng, Y., Yang, Y., Chen, S., Li, J., Gao, D., Sun, W., Wu, Z., Zhou, Y., et al. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202401851 · Cited by 15

Metastatic Salivary Gland Tumors: A Single-Center Study Demonstrating the Feasibility and Potential Clinical Benefit of Molecular-Profiling-Guided Therapy

Popovtzer, A., Sarfaty, M., Limon, D., Marshak, G., Perlow, E., Dvir, A., Soussan‐Gutman, L., & Stemmer, S. M. (2015) · BioMed Research International · doi:10.1155/2015/614845 · Cited by 15

A sequence-specific DNA binding small molecule triggers the release of immunogenic signals and phagocytosis in a model of B-cell lymphoma

Kang, J. S., & Dervan, P. B. (2015) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583515000104 · Cited by 15

Novel Targeted Agents and Immunotherapy in Breast Cancer

Mayer, I. A., Dent, R. A., Tan, T. J., Savas, P. S., & Loi, S. (2017) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_175631 · Cited by 14

Immediate and substantial evolution of T-cell repertoire in peripheral blood and tumor microenvironment of patients with esophageal squamous cell carcinoma treated with preoperative chemotherapy

Zhang, C., Palashati, H., Tan, Q., Ku, W., Yu, M., Xiong, H., & Lu, Z. (2018) · Carcinogenesis · doi:10.1093/carcin/bgy116 · Cited by 15

Clinicopathological and prognostic significance of high circulating lymphocyte ratio in patients receiving neoadjuvant chemotherapy for advanced gastric cancer

Li, Y., Yao, W., He, Q., Wang, X., Fan, C., & Li, G. (2018) · Scientific Reports · doi:10.1038/s41598-018-24259-5 · Cited by 15

Genetic associations of T cell cancer immune response-related genes with T cell phenotypes and clinical outcomes of early-stage lung cancer

Wang, Q., Gu, J. H., Wang, L., Chang, D. W., Ye, Y., Huang, M., Roth, J. A., & Wu, X. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2019-000336 · Cited by 15

Assessment of Genotoxic potential of Annonacin and Annona muricata L. extracts on human breast cancer (MCF-7) cells

Naik, A. V., & Sellappan, K. (2020) · Oriental Pharmacy and Experimental Medicine · doi:10.1007/s13596-020-00517-8 · Cited by 15

Navigate Towards the Immunotherapy Era: Value of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer Patients With Brain Metastases

Yang, G., Xing, L., & Sun, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.852811 · Cited by 15

A combination of stromal PD‐L1 and tumoral nuclear β‐catenin expression as an indicator of colorectal carcinoma progression and resistance to chemoradiotherapy in locally advanced rectal carcinoma

Takahashi, H., Watanabe, H., Hashimura, M., Matsumoto, T., Yokoi, A., Nakagawa, M., Ishibashi, Y., Ito, T., Ohhigata, K., & Saegusa, M. (2022) · The Journal of Pathology Clinical Research · doi:10.1002/cjp2.285 · Cited by 15

Chemotherapy and Physical Therapeutics Modulate Antigens on Cancer Cells

Szlasa, W., Janicka, N., Sauer, N., Michel, O., Nowak, B., Saczko, J., & Kulbacka, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.889950 · Cited by 15

Excessive HSP70/TLR2 activation leads to remodeling of the tumor immune microenvironment to resist chemotherapy sensitivity of mFOLFOX in colorectal cancer

Feng, H., Guo, Z., Chen, X., Liu, K., Li, H., Jia, W., Wang, C., Luo, F., Ji, X., Zhang, T., et al. (2022) · Clinical Immunology · doi:10.1016/j.clim.2022.109157 · Cited by 16

Immunothérapie des cancers

Tartour, É., Sandoval, F., Bonnefoy, J., & Fridman, W. H. (2011) · médecine/sciences · doi:10.1051/medsci/20112710011 · Cited by 15

TRAIL Receptor Signaling Regulation of Chemosensitivity In Vivo but Not In Vitro

Menke, C., Goncharov, T., Qamar, L., Korch, C. T., Ford, H. L., Behbakht, K., & Thorburn, A. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0014527 · Cited by 15

Immunotherapy for advanced or relapsed cervical cancer

Lin, C., Wang, C., & Lai, C. (2013) · Gynecology and Minimally Invasive Therapy · doi:10.1016/j.gmit.2012.12.001 · Cited by 15

White Blood Cell and Granulocyte Counts Are Independent Predictive Factors for Prognosis of Advanced Pancreatic Caner

Feng, L., Gu, S., Wang, P., Chen, H., Chen, Z., Meng, Z., & Liu, L. (2018) · Gastroenterology Research and Practice · doi:10.1155/2018/8096234 · Cited by 16

Control in dormancy or eradication of cancer stem cells: Mathematical modeling and stability issues

Djema, W., Bonnet, C., Mazenc, F., Clairambault, J., Fridman, E., Hirsch, P., & Delhommeau, F. (2018) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2018.03.038 · Cited by 15

Immune Reconstitution Following Hematopoietic Cell Transplantation

Dudakov, J. A., Perales, M., & van den Brink, M. R. M. (2015) · Wiley eBooks · doi:10.1002/9781118416426.ch15 · Cited by 13

Perioperative serplulimab with neoadjuvant chemotherapy versus perioperative chemotherapy in PD-L1-positive gastric cancer (ASTRUM-006): a randomised, double-blind, multicentre, phase 3 study

Shen, L., Zhang, X., Ji, K., Lu, L., Wang, Q., Guan, Q., Yan, S., Zhou, Y., Yang, Y., Huo, Z., et al. (2026) · The Lancet · doi:10.1016/s0140-6736(26)00974-8 · Cited by 14

The Biomodulatory Capacities of Low-Dose Metronomic Chemotherapy: Complex Modulation of the Tumor Microenvironment

Emmenegger, U., Chow, A., & Bocci, G. (2010) · Springer eBooks · doi:10.1007/978-90-481-9531-2_11 · Cited by 14

Chemotherapy for Lung Cancers: Here to Stay

Kris, M. G., Hellmann, M. D., & Chaft, J. E. (2014) · American Society of Clinical Oncology Educational Book · doi:10.14694/edbook_am.2014.34.e375 · Cited by 15

PD-L1 expression as a prognostic marker in patients treated with chemotherapy for metastatic non-small-cell lung cancer

Woodford, R. G., Zhou, D. D.-X., Lord, S. J., Marschner, I. C., Cooper, W. A., Lewis, C. R., John, T., Yang, J. C., & Lee, C. K. (2022) · Future Oncology · doi:10.2217/fon-2021-1184 · Cited by 15

A promising self-nanoemulsifying adjuvant with plant-derived saponin D boosts immune response and exerts an anti-tumor effect

Luo, X., Song, Z., Zeng, X., Yan, Y., Zheng, H., Cai, D., Yuan, Q., Li, H., Tong, Y., Lu, D., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1154836 · Cited by 14

STING-targeted PET tracer for early assessment of tumor immunogenicity in colorectal cancer after chemotherapy

Xu, D., Lu, X., Yang, F., Jiang, Z., Yang, S., Bi, L., Liu, J., Shan, H., & Li, D. (2023) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-023-06485-w · Cited by 15

Cell Identity and Spatial Distribution of PD‐1/PD‐L1 Blockade Responders

Li, X., Liu, Y., Gui, J., Gan, L., & Xue, J. (2024) · Advanced Science · doi:10.1002/advs.202400702 · Cited by 17

Tumor-infiltrating myeloid cells; mechanisms, functional significance, and targeting in cancer therapy

Toghraie, F. S., Bayat, M., Hosseini, M. S., & Ramezani, A. (2025) · Cellular Oncology · doi:10.1007/s13402-025-01051-y · Cited by 18

Manganese-based virus-mimicking nanomedicine with triple immunomodulatory functions inhibits breast cancer brain metastasis

Zhao, Z., Zhou, J., Li, X., Zhang, T., Tian, Z., Sun, T., & Jiang, C. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123262 · Cited by 14

In silico tumor control induced via alternating immunostimulating and immunosuppressive phases

Reppas, A., Alfonso, J., & Hatzikirou, H. (2015) · Virulence · doi:10.1080/21505594.2015.1076614 · Cited by 14

Immunocombination Therapy for High-Risk Neuroblastoma

Kroesen, M., Lindau, D., Hoogerbrugge, P. M., & Adema, G. J. (2012) · Immunotherapy · doi:10.2217/imt.11.169 · Cited by 14

Role of 13C-Urea Breath Test in Experimental Model of Helicobacter pylori Infection in Mice

Santos, A. M., Lopes, T., Oleastro, M., Chaves, P. P., Cordeiro, R., Ferreira, M. M. F., Pereira, T., Machado, J., & Guerreiro, A. S. (2011) · Helicobacter · doi:10.1111/j.1523-5378.2011.00847.x · Cited by 14

Remarkable response to pembrolizumab with platinum‐doublet in PD‐L1‐low pulmonary sarcomatoid carcinoma: A case report

Taniguchi, H., Takemoto, S., Ozasa, M., Honda, N., Suyama, T., Umeyama, Y., Dotsu, Y., Nakao, T., Tomohito, K., Gyotoku, H., et al. (2021) · Thoracic Cancer · doi:10.1111/1759-7714.13890 · Cited by 15

Immune-based mechanisms of cytotoxic chemotherapy: implications for the design of novel and rationale-based combined treatments against cancer

Bracci, L., Schiavoni, G., Sistigu, A., & Belardelli, F. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.67 · Cited by 951

Immune Effects of Conventional Cancer Therapeutics

Demaria, S., & Galluzzi, L. (2018) · Springer Publishing Company eBooks · doi:10.1891/9781617052736.0022

Activation of Immune-Mediated Tumor Cell Death by Chemotherapy

McCoy, M. J., Nowak, A. K., & Lake, R. (2012) · Springer eBooks · doi:10.1007/978-1-4614-5847-0_14

Prerequisites for the Antitumor Vaccine-Like Effect of Chemotherapy and Radiotherapy

Hannani, D., Sistigu, A., Kepp, O., Galluzzi, L., Kroemer, G., & Zitvogel, L. (2011) · The Cancer Journal · doi:10.1097/ppo.0b013e3182325d4d · Cited by 88

Immunogenic effects of chemotherapy-induced tumor cell death

Wang, Y., Fletcher, R., Yu, J., & Zhang, L. (2018) · Genes & Diseases · doi:10.1016/j.gendis.2018.05.003 · Cited by 328